The prospects for using the genetically engineered surface antigen of the hepatitis B virus (HBsAg) expressed by recombinant poxvirus strains as the basis for vaccines against hepatitis B
Zheleznova, N V, Mukomolov, S L, Zhebrun, A B, Noskov, F S, Malkova, I I, Shargorodskaia, E P, Al'tshteĭn, A D, Pliutnikova, V A, Lavrent'eva, I N, Ptichnikova, N N
Published in Žurnal mikrobiologii, ėpidemiologii i immunobiologii (01.09.1996)
Get more information
Published in Žurnal mikrobiologii, ėpidemiologii i immunobiologii (01.09.1996)
Journal Article